These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33368325)

  • 1. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments.
    Leiva MC; Garre E; Gustafsson A; Svanström A; Bogestål Y; Håkansson J; Ståhlberg A; Landberg G
    J Cell Physiol; 2021 Jun; 236(6):4709-4724. PubMed ID: 33368325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features.
    Leiva MC; Gustafsson A; Garre E; Ståhlberg A; Kovács A; Helou K; Landberg G
    J Transl Med; 2023 Dec; 21(1):924. PubMed ID: 38124067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery.
    Svanström A; Rosendahl J; Salerno S; Leiva MC; Gregersson P; Berglin M; Bogestål Y; Lausmaa J; Oko A; Chinga-Carrasco G; Petronis S; Standoft S; Ståhlberg A; Håkansson J; Landberg G
    Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34030145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived scaffolds influence secretion profiles in cancer cells mirroring clinical features and breast cancer subtypes.
    Persson E; Gregersson P; Gustafsson A; Fitzpatrick P; Rhost S; Ståhlberg A; Landberg G
    Cell Commun Signal; 2021 Jun; 19(1):66. PubMed ID: 34090457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells.
    Sharma B; Varney ML; Saxena S; Wu L; Singh RK
    Cancer Lett; 2016 Mar; 372(2):192-200. PubMed ID: 26797460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional tissue culture model of human breast cancer for the evaluation of multidrug resistance.
    Ding Y; Liu W; Yu W; Lu S; Liu M; Kaplan DL; Wang X
    J Tissue Eng Regen Med; 2018 Sep; 12(9):1959-1971. PubMed ID: 30055109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment.
    Reynolds DS; Tevis KM; Blessing WA; Colson YL; Zaman MH; Grinstaff MW
    Sci Rep; 2017 Sep; 7(1):10382. PubMed ID: 28871147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrichment of breast cancer stem-like cells by growth on electrospun polycaprolactone-chitosan nanofiber scaffolds.
    Sims-Mourtada J; Niamat RA; Samuel S; Eskridge C; Kmiec EB
    Int J Nanomedicine; 2014; 9():995-1003. PubMed ID: 24570583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
    Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
    Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
    Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
    Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human breast cancer decellularized scaffolds promote epithelial-to-mesenchymal transitions and stemness of breast cancer cells in vitro.
    Liu G; Wang B; Li S; Jin Q; Dai Y
    J Cell Physiol; 2019 Jun; 234(6):9447-9456. PubMed ID: 30478896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously.
    Hii LW; Chung FF; Soo JS; Tan BS; Mai CW; Leong CO
    Breast Cancer Res Treat; 2020 Feb; 179(3):615-629. PubMed ID: 31784862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting
    Shen M; Dong C; Ruan X; Yan W; Cao M; Pizzo D; Wu X; Yang L; Liu L; Ren X; Wang SE
    Cancer Res; 2019 Jul; 79(14):3608-3621. PubMed ID: 31118200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.
    Fillmore CM; Kuperwasser C
    Breast Cancer Res; 2008; 10(2):R25. PubMed ID: 18366788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of ABCB1, β tubulin I, and III with multidrug resistance of MCF7/DOC subline from breast cancer cell line MCF7.
    Li W; Zhai B; Zhi H; Li Y; Jia L; Ding C; Zhang B; You W
    Tumour Biol; 2014 Sep; 35(9):8883-91. PubMed ID: 24894670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer.
    Wang Z; Kong J; Wu Y; Zhang J; Wang T; Li N; Fan J; Wang H; Zhang J; Ling R
    Breast Cancer Res Treat; 2018 Apr; 168(2):531-542. PubMed ID: 29185119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.
    Yakisich JS; Venkatadri R; Azad N; Iyer AKV
    J Cell Physiol; 2017 Aug; 232(8):2033-2043. PubMed ID: 27504932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells.
    Hu K; Law JH; Fotovati A; Dunn SE
    Breast Cancer Res; 2012 Feb; 14(1):R22. PubMed ID: 22309939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
    Watanabe T; Oba T; Tanimoto K; Shibata T; Kamijo S; Ito KI
    PLoS One; 2021; 16(6):e0252822. PubMed ID: 34101751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study with cancer stem cells and three-dimensional tumoroids: investigation of the combined effects of 5-fluorouracil and doxorubicin in breast cancer.
    Erden Tayhan S
    Med Oncol; 2024 Jun; 41(7):185. PubMed ID: 38910198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.